Protein kinase C changes in diabetes: Is the concept relevant to neuropathy?

Ahlgren, 1994, Protein kinase C inhibitors decrease hyperalgesia and Gfiber hyperexcitability in the streptozotocin-diabetic rat, J. Neurophysiol., 72, 684, 10.1152/jn.1994.72.2.684 Ahlgren, 1992, Increased responsiveness of sensory neurons in the saphenous nerve of the streptozotocin-diabetic rat, J. Neuraphysiol., 68, 2077, 10.1152/jn.1992.68.6.2077 Borghini, 1994, Alpha, beta I, beta II, delta and epsilon protein kinase C isoforms and compound activity in the sciatic nerve of normal and diabetic rats.), J. Neurochem., 62, 686, 10.1046/j.1471-4159.1994.62020686.x Borghini, 1994, In vivo phosphorylation of the Na, KATPase a subunit in sciatic nerves of control and diabetic rats: Effects of protein kinase modulators, 91, 6211 Brunden, 1987, A phorbol ester-sensitive kinase catalyzes the phosphorylation of P0 glycoprotein in myelin, J. Neurochem., 46, 1863, 10.1111/j.1471-4159.1987.tb02448.x Cameron, 1994, The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications, Diabet. Metab. Rev., 10, 189, 10.1002/dmr.5610100302 Cameron, 1999, Effect of antioxidants on nerve and vascular dysfunction in experimental diabetes, Diabet. Res. Clin. Prac., 45, 137, 10.1016/S0168-8227(99)00043-1 Cameron, 1999, Protein kinase C effects on nerve function, perfusion, Na(+),K(+) ATPase activity and glutathione content in diabetic rats, Diabetologia, 42, 1120, 10.1007/s001250051280 Chang, 1997, Increased sciatic nerve blood flow in diabetic rats: Assessment by “molecular” vs. particulate microspheres, Am. J Physiol., 273, 164 Chattopadhyay, 1992, Nonesterified fatty acids in normal and diabetic rat sciatic nerve, Lipids, 27, 513, 10.1007/BF02536133 Craven, 1990, Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids, Diabetes, 39, 667, 10.2337/diabetes.39.6.667 Craven, 1989, Protein kinase C is activated in glomeruli from streptozotocin diabetic rats: Possible mediation by glucose, J. Clin. Invest., 83, 1667, 10.1172/JCI114066 Dekker, 2000, Protein kinase C-β contributes to NADPH oxidase activation in neutrophils, Biochem. J, 347, 285, 10.1042/0264-6021:3470285 Delacroix, 1998, Effect of nerve growth factor treatment on p75NTR gene expression in lumbar dorsal root ganglia of streptozotocin-induced diabetic rats, Diabetes, 47, 1779, 10.2337/diabetes.47.11.1779 Dempsey, 2000, Protein kinase C isozymes and the regulation of diverse cell responses, Am. J. Physiol. Lung Cell Mol. Physiol., 279, L429, 10.1152/ajplung.2000.279.3.L429 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N. Engl. J. Med., 329, 977, 10.1056/NEJM199309303291401 Dina, 2000, Key role for the epsilon isoform of protein kinase C in painful alcoholic neuropathy in the rat, J. Neurosci., 20, 8614, 10.1523/JNEUROSCI.20-22-08614.2000 Dines, 1999, Effects of hindlimb temperature on sciatic nerve laser Doppler vascular conductance in control and streptozotocin-diabetic rats, J. Neurol. Sci., 163, 17, 10.1016/S0022-510X(99)00013-1 Du, 2001, Fatty acids inhibit growth factorinduced diacylglycerol kinase α activation in vascular smooth muscle cells, Biochem., 357, 275, 10.1042/0264-6021:3570275 Dutil, 2000, Dual role of pseudosubstrate in the coordinated regulation of protein kinase C by phosphorylation and diacylglycerol, J. Biol. Chem., 275, 10697, 10.1074/jbc.275.14.10697 Eichberg, 1996, Phosphorylation of myelin proteins: Recent advances, Neurochem. Res., 21, 527, 10.1007/BF02527718 Fernyhough, 1995, Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat, Eur. J. Neurosci., 7, 1107, 10.1111/j.1460-9568.1995.tb01098.x Feschenko, 2000, Interaction of protein kinase C and CAMP-dependent pathways in the phosphorylation of the Na,KATPase, J. Biol. Chem., 275, 34693, 10.1074/jbc.M005869200 Feschenko, 1997, Phosphorylation of Na,K-ATPase by protein kinase C at ser18 occurs in intact cells but does not result in direct inhibition of ATP hydrolysis, J. Biol. Chem., 272, 17726, 10.1074/jbc.272.28.17726 Ganz, 2000, Glucose-induced changes in protein kinase C and nitric oxide are prevented by vitamin E, Am. J. Physiol. Endocrinol. Metab., 278, E146, 10.1152/ajpendo.2000.278.1.E146 Gao, 2001, The carboxyl terminus of protein kinase C provides a switch to regulate its interaction with the phosphoinositide-dependent kinase, PDK1, J. Biol. Chem., 276, 19588, 10.1074/jbc.M101357200 Gokmen-Polar, 1998, Mapping of a molecular determinant for protein kinase C betaII isozyme function, J. Biol. Chem., 273, 20261, 10.1074/jbc.273.32.20261 Greene, 1989, Pathogenesis of diabetic neuropathy: Role of altered phosphoinositide metabolism, Crit. Rev. Neurobiol., 5, 143 Haller, 1995, High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells, Kidney Int., 47, 1057, 10.1038/ki.1995.152 Hermenegildo, 1992, Inhibition of protein kinase C restores Na+,K+-ATPase activity in sciatic nerve of diabetic mice, J. Neurochem., 58, 1246, 10.1111/j.1471-4159.1992.tb11335.x Hermenegildo, 1993, Sustained recovery of Na+-K+-ATPase activity in sciatic nerve of diabetic mice by administration of H7 or calphostin C, inhibitors of PKC, Diabetes, 42, 257, 10.2337/diabetes.42.2.257 Hink, 2001, Mechanisms underlying endothelial cell dysfunction in diabetes mellitus, Circ. Res., 88, E14, 10.1161/01.RES.88.2.e14 Ido, 1997, Diabetes impairs sciatic nerve hyperemia induced by surgical trauma: Implications for diabetic neuropathy, Am. J. Physiol., 273, E174 Ido, 1994, Neural dysfunction and metabolic imbalances in diabetic rats: Prevention by acetyl-L-carnitine, Diabetes, 43, 1269, 10.2337/diabetes.43.12.1469 Idris, 2001, Protein kinase C activation: Isozyme-specific effects on metabolism and cardiovascular complications in diabetes, Diabetologia, 44, 659, 10.1007/s001250051675 Igarashi, 1999, Glucose or diabetes activates p38 mitogenactivated protein kinase via different pathways, J. Clin. Invest., 103, 183, 10.1172/JCI3326 Inoguchi, 1992, Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: Differential reversibility to glycemic control by islet cell transplantation, 89, 11059 Inoguchi, 2000, High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD (P) H oxidase in cultured vascular cells, Diabetes, 49, 1939, 10.2337/diabetes.49.11.1939 Ishii, 1996, Amelioration of vascular dysfunction in diabetic rats by an oral PKC β inhibitor, Science, 272, 728, 10.1126/science.272.5262.728 Jack, 1999, Effects of the diacylglycerol complexing agent, cremophor, on nerve conduction velocity and perfusion in diabetic rats, J. Diabet. Complicat., 13, 2, 10.1016/S1056-8727(98)00014-2 Jirousek, 1996, (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16,21 dimetheno-lH,13H-dibenzo [e,k] pyrrolo [3,4-h] [1,4,13] oxadiazacyclohexadecene-1,3(2H)d ione (LY and related analogues: Isozyme selective inhibitors of protein kinase C beta, J. Med. Chem., 39, 2664, 10.1021/jm950588y Johnson, 2000, The Cl and C2 domains of protein kinase C are independent membrane targeting modules, with specificity for phosphatidylserine conferred by the Cl domain, Biochemistry, 39, 11360, 10.1021/bi000902c Kang, 1999, Differential expression of protein kinase C isoforms in streptozotocin-induced diabetic rats, Kidney Int., 56, 1737, 10.1046/j.1523-1755.1999.00725.x Khasar, 1999, A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice, Neuron, 24, 253, 10.1016/S0896-6273(00)80837-5 Kikkawa, 1989, The protein kinase C family: Heterogeneity and its implications, Annu. Rev. Biochem., 58, 31, 10.1146/annurev.bi.58.070189.000335 Kiley, 1995, Differential localization of protein kinase C isozymes in U937 cells: Evidence for distinct isozyme functions during monocyte differentiation, J. Cell Sci., 108, 1003, 10.1242/jcs.108.3.1003 Kim, 1991, Normalization of Na+-ATPase activity in isolated membrane fraction from sciatic nerves of streptozotocin-induced diabetic rats by dietary myo-inositol supplementation in vivo or protein kinase C agonists in vitro, Diabetes, 40, 558, 10.2337/diabetes.40.5.558 Kishi, 1999, α-Lipoic acid: Effect on glucose uptake, sorbitol pathway and energy metabolism in experimental diabetic neuropathy, Diabetes, 48, 2045, 10.2337/diabetes.48.10.2045 Knapp, 2000, Superoxide-induced stimulation of protein kinase C via thiol modification and modulation of zinc content, J. Biol. Chem., 275, 24136, 10.1074/jbc.M002043200 Korchak, 2001, Roles for βII-protein kinase C and RACK1 in positive and negative signaling for superoxide anion generation in differentiated HL-60 cells, J. Biol. Chem., 276, 8910, 10.1074/jbc.M008326200 Kowluru, 1998, Abnormalities of retinal metabolism in diabetes or experimental galactosemia: Relationship between protein kinase C and ATPases, Diabetes, 47, 464, 10.2337/diabetes.47.3.464 Koya, 2000, Amelioration of accelerated diabetes mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model of type 2 diabetes, FASEB J., 14, 439, 10.1096/fasebj.14.3.439 Koya, 1998, Protein kinase C activation and the development of diabetic complications, Diabetes, 47, 859, 10.2337/diabetes.47.6.859 Kunisaki, 1994, Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels, Diabetes, 43, 1372, 10.2337/diabetes.43.11.1372 Lattimer, 1989, In vivo correction of Na+,K+-ATPase activity in diabetic nerve by protein kinase C agonists, Am. J. Physiol., 256, E264 Lee, 1999, d-alpha tocopherol prevents the hyperglycemia induced activation of diacylglycerol (DAG) -protein kinase C pathway in vascular smooth muscle cells by an increase of DAG kinase activity, Diabet. Res. Clin. Pract., 45, 183, 10.1016/S0168-8227(99)00048-0 Lee, 1989, Activation of protein kinase C activity by elevation of glucose concentration: Proposal for a mechanism in the development of diabetic vascular complications, 86, 5141 Lu, 2000, Fatty acids modulate protein kinase C activation in porcine vascular smooth muscle cells independently of their effect on de novo diacylglycerol synthesis, Diabetologia, 43, 1136, 10.1007/s001250051504 Malik, 1995, Mendenhall's syndrome: Clues to the aetiology of human diabetic neuropathy, J. Neurol. Neurosurg. Psychiatry, 58, 493, 10.1136/jnnp.58.4.493 Mathew, 1997, Phosphoinositide metabolism, Na, KATPase and protein kinase C are altered in peripheral nerve from Zucker diabetic fatty rats, Neurosci. Res. Commun., 20, 21, 10.1002/(SICI)1520-6769(199701)20:1<21::AID-NRC182>3.0.CO;2-A Mellor, 1998, The extended protein kinase C superfamily, Biochem. J., 332, 281, 10.1042/bj3320281 Mochly-Rosen, 1998, Anchoring proteins for protein kinase C: A means for isozyme selectivity, FASEBJ, 12, 35, 10.1096/fasebj.12.1.35 Mosior, 1998, Mechanism of the apparent cooperativity in the interaction of protein kinase C with phosphatidylserine, Biochemistry, 37, 17271, 10.1021/bi981344t Murray, 1998, Phosphatidylglycerol is a physiologic activator of nuclear protein kinase C., J. Biol. Chem., 273, 11514, 10.1074/jbc.273.19.11514 Nakamura, 2001, Glucose-induced hyperproliferation of cultured rat aortic smooth muscle cells through polyol pathway hyperactivity, Diabetologia, 44, 480, 10.1007/s001250051646 Nakamura, 1999, A protein kinase C-β-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats, Diabetes, 48, 290, 10.2337/diabetes.48.10.2090 Newton, 2001, Protein kinase C: Structural and spatial regulation by phosphorylation, cofactors and macromolecular interactions, Chem. Rev., 101, 2353, 10.1021/cr0002801 Nishikawa, 2000, Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage, Nature, 404, 787, 10.1038/35008121 Nishizuka, 1984, The role of protein kinase C in cell surface signal transduction and tumour promotion, Nature, 308, 693, 10.1038/308693a0 Nobe, 1998, Alterations of diacylglycerol kinase in streptozotocin-induced diabetic rats, Cell Signal., 10, 465, 10.1016/S0898-6568(97)00172-1 O'Flaherty, 2001, Protein kinase C translocation responses to low concentrations of arachidonic acid, J. Biol. Chem., 276, 24743, 10.1074/jbc.M101093200 Park, 2000, Induction of endothelin-1 expression by glucose: An effect of protein kinase C activation, Diabetes, 49, 1239, 10.2337/diabetes.49.7.1239 Parker, 1999, Inhibition of protein kinase C-do we, can we, and should we?, Pharmacol. Ther., 82, 263, 10.1016/S0163-7258(98)00047-3 Roberts, 1997, Protein kinase C isozyme expression in sciatic nerve and spinal cords of experimentally diabetic rats, Brain Res., 754, 147, 10.1016/S0006-8993(97)00062-0 Rosen, 2001, The role of oxidative stress in the onset and progression of diabetes and its complications: A summary of a Congress series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetic Society, Diabet. Metab. Res. Rev., 17, 189, 10.1002/dmrr.196 Rowe-Rendleman, 1994, P0 phosphorylation in nerves from normal and diabetic rats: Role of protein kinase C and turnover of phosphate groups, Neurochem. Res., 19, 1023, 10.1007/BF00968712 Russell, 1999, Insulin-like growth factor-I prevents apoptosis in sympathetic neurons exposed to high glucose, Horn. Metab. Res., 31, 90, 10.1055/s-2007-978704 Russell, 1999, Neurons undergo apoptosis in animal and cell culture models of diabetes, Neurobiol. Dis., 6, 347, 10.1006/nbdi.1999.0254 Samii, 1999, Vascular endothelial growth factor expression in peripheral nerves and dorsal root ganglia in diabetic neuropathy in rats, Neurosci. Lett., 262, 159, 10.1016/S0304-3940(99)00064-6 Schneider, 1992, Differences in sensitivity to hyperglycemic hypoxia of isolated rat sensory and motor nerve fibers, Ann. Neurol., 31, 605, 10.1002/ana.410310607 Schrama, 1987, Altered protein phosphorylation in sciatic nerve from rats with streptozotocin-induced diabetes, Diabetes, 36, 1254, 10.2337/diabetes.36.11.1254 Schratzberger, 2001, Reversal of experimental diabetic neuropathy by VEGF gene transfer, J. Clin. Invest., 107, 1083, 10.1172/JCI12188 Scivittaro, 2000, AGES induce oxidative stress and activate protein kinase βII in neonatal mesangial cells, Am. J. Physiol. Renal Physiol., 278, F676, 10.1152/ajprenal.2000.278.4.F676 Setton-Avruj, 2001, Protein kinase C in peripheral myelin from control and streptozotocin-induced diabetic rats: Regulation by phosphatidic acid phospohydrolase, J. Neurochem., 78, 143 Shimomura, 1991, Synergistic action of diacylglycerol and unsaturated fatty acids for PKC activation: Its possible implication, 88, 5149 Simpson, 1988, Reduced Na++ K+-ATPase activity in peripheral nerve of streptozotocin-diabetic rats: A role for protein kinase C?, Diabetologia, 31, 297 Tammariello, 2000, NADPH oxidase contributes directly to oxidative stress and apoptosis in nerve growth factor-deprived sympathetic neurons, 20, 1 Tang, 1993, Diabetes induces selective alterations in the expression of protein kinase C isoforms in hepatocytes, FEBS Lett., 326, 117, 10.1016/0014-5793(93)81774-T 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N. Engl. J Med., 329, 977, 10.1056/NEJM199309303291401 Thomas, 1993, Diabetic and hypoglycemic neuropathy, 1219 Tomlinson, 1999, Mitogen-activated protein kinases as glucose transducers in diabetic complications, Diabetologia, 42, 1271, 10.1007/s001250051439 Tomlinson, 1993, Modulation of the sodiumpotassium pump of peripheral nerve-pharmacological manipulation of protein kinase C, Mol. Neuropharmacol., 3, 133 Tomlinson, 1996, Dependence of sciatic nerve blood flowon hind-limb muscle mass: An explanation for the deficits in nerve perfusion in experimental diabetes, Diabet. Nutr. Metab., 9, 258 Tran, 1994, Vitamin E suppresses diacylglycerol (DAG) level in thrombin-stimulated endothelial cells through an increase of DAG kinase activity, Biochim. Biophys. Acta, 1212, 193, 10.1016/0005-2760(94)90253-4 Way, 2000, Identification of PKC-isoform-specific biological actions using pharmacological approaches, Trends Pharmacol. Sci., 21, 181, 10.1016/S0165-6147(00)01468-1 Ways, 2000, The role of protein kinase C in the development of the complications of diabetes, Vit. Horm., 60, 149, 10.1016/S0083-6729(00)60019-5 Xia, 1996, Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth, J. Clin. Invest., 98, 2018, 10.1172/JCI119006 Xia, 1994, Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia, Diabetes, 43, 1122, 10.2337/diabetes.43.9.1122 Xia, 1995, Identification of the mechanism for the inhibition of Na+,K+-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2, J. Clin. Invest., 96, 733, 10.1172/JCI118117 Yamagishi, 2001, Alterations of protein kinase C activity in peripheral nerve of STZ-induced diabetic mice overexpressing human aldose reductase, Diabetes, 50, A190 Yan, 1994, Enhanced oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins, J. Biol. Chem., 269, 9889, 10.1016/S0021-9258(17)36966-1 Yu, 2001, Saturated non-esterified fatty acids stimulate de novo diacylglycerol synthesis and protein kinase C activity in cultured aortic smooth muscle cells, Diabetologia, 44, 614, 10.1007/s001250051668 Zhu, 1990, 1,2-Diacylglycerol content and its arachidonylcontaining molecular species are reduced in sciatic nerve from streptozotocin-induced diabetic rats, J. Neurochem., 55, 1087, 10.1111/j.1471-4159.1990.tb04604.x Zochodne, 1999, Diabetic neuropathies: Features and mechanisms, Brain Pathol., 9, 369, 10.1111/j.1750-3639.1999.tb00233.x Zochodne, 1992, Normal blood flow but lower oxygen tension in diabetes of young rats: Microenvironment and the influence of sympathectomy, Can. J. Physiol. Pharmacol., 70, 651, 10.1139/y92-083